Back

Early in-hospital initiation of SGLT2 inhibitors in acute decompensated heart failure

12 May 2024 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure 1 Treatment HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Luis Eduardo Echeverria

Fundacion Cardiovascular de Colombia, Floridablanca (Colombia)

3 More presentations in this session

Presentation thumbnail
Lung ultrasound in acute heart failure: a head-to-head comparison with other modalities to detect pulmonary congestion
Doctor K. Miger (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Short-term echocardiographic and biomarker changes in de-novo heart failure versus acutely decompensated chronic heart failure
Doctor H. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Pulmonary artery catheterization in cardiogenic shock: a propensity matched analysis on management and prognostic impact
Doctor A. Bello (Carnaxide, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure 1

The Event

Event poster

Heart Failure 2024

12 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Timing matters: clinical outcomes of early sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure
thumbnail
Congress Presentation
Initiation of SGLT2I during acute HF hospitalization or in the immediate period following discharge.
thumbnail
Congress Presentation
The in-hospital use of SGLT2i in heart failure with ischemic aetiology and recent acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources